Similar articles

• Proceedings: The induction of gonadotrophin secretion with repeated subcutaneous injections of luteinizing hormone-follicle-stimulating hormone releasing hormone in men with hypogonadotrophic hypogonadism.

  Mortimer CH, Besser GM, McNeilly AS. Mortimer CH, et al. J Endocrinol. 1974 May;61(2):LXI-LXII. J Endocrinol. 1974. PMID: 4600119 No abstract available.
• [24-hour integrated concentration of LH, FSH, TSH and PRL in subjects with hypogonadotropic hypogonadism treated with pulsatile LHRH].

  Torre R, Giusti M, Traverso L, Cavagnaro P, Giordano G. Torre R, et al. Minerva Endocrinol. 1988 Oct-Dec;13(4):223-9. Minerva Endocrinol. 1988. PMID: 3148103 Italian. No abstract available.
• Role of pulsatile luteinizing hormone releasing-hormone therapy in males with idiopathic hypogonadotropic hypogonadism and delayed puberty.

  Giusti M, Cavagnaro P, Torre R. Giusti M, et al. Recenti Prog Med. 1991 Jan;82(1):47-53. Recenti Prog Med. 1991. PMID: 1902963 Review.
• [Pulsatile long-term gonadotropin-releasing hormone (GnRH) therapy in the male: natural induction of puberty in a 20-year-old boy].

  Trost BN. Trost BN. Schweiz Med Wochenschr. 1986 Dec 13;116(50):1776-9. Schweiz Med Wochenschr. 1986. PMID: 3099383 German.
• Clinical effects and uses of hypothalamic releasing and inhibiting factors.

  Gual C. Gual C. Front Neuroendocrinol. 1973;0(0):89-131. Front Neuroendocrinol. 1973. PMID: 4212997 Review. No abstract available.